Skip to main content

Non-Thyroidal Complications of Graves’ Disease: Perspective On Pathogenesis And Treatment

  • Chapter
Thyroid Autoimmunity

Abstract

A substantial number of patients with Graves’ disease have significant and sometimes disabling abnormalities in sites anatomically remote from the thyroid, such as in orbital tissues (ophthalmopathy), pretibial skin (dermopathy), and bones of the extremities (acropachy).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams DD, Purves HD, Abnormal responses in the assay of thyrotropin, Proc Univ Otago Med School 34:11–12, 1956.

    Google Scholar 

  2. McKenzie JM, Delayed response to serum from thyrotoxic patients, Endocrinology 62:865–868, 1958.

    Article  PubMed  CAS  Google Scholar 

  3. Kriss JP, Pleshakov V, Chien JR, Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema, J Clin Endocrinol Metab 24:1005–1028, 1964.

    Article  PubMed  CAS  Google Scholar 

  4. McKenzie JM, Zakarija M, LATS in Graves’ disease, Recent Prog Horm Res 33:29–53, 1977.

    Google Scholar 

  5. Yavin E, Yavin Z, Schneider MD, Kohn LD, Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves’ disease, Proc Natl Acad Sci USA 78:3180–2184, 1980.

    Article  Google Scholar 

  6. Matsukura N, Yamada Y, Nohara Y, Konishi J, Kasagi K, Kojima H, Wataya K, Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins, New Engl J Med 303:738–741, 1980.

    Article  Google Scholar 

  7. Valente WA, Vitti P, Yavin Z, Yavin E, Rotella CM, Grollman EF, Toccafondi RS, Kohn LD, Monoclonal antibodies to the thyrotropin receptor: Stimulating and blocking antibodies derived from the lymphocytes of patients with Graves’ disease, Proc Natl Acad Sci USA 79:6680–6684, 1982.

    Article  PubMed  CAS  Google Scholar 

  8. Atkinson S, Kendall-Taylor P, The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies, J Clin Endocrinol Metab 53:1263–1266, 1981.

    Article  PubMed  CAS  Google Scholar 

  9. Kodama K, Sikorska P, Bandy-Dafoe K, Wall JR, Demonstration of a circulating autoantibody against soluble eye-muscle antigen in Graves’ ophthalmopathy, Lancet ii:1353–1356 1982.

    Article  Google Scholar 

  10. Faryna M, Nauman J, Gardos A, Measurement of autoantibodies against human eye muscle membranes in Graves’ ophthalmopathy, Brit Med J 290:191–192, 1985.

    Article  CAS  Google Scholar 

  11. Atkinson S, Holcombe M, Kendall-Taylor P, Ophthalmopathic immunoglobulin in patients with Graves’ ophthalmopathy, Lancet 11:374–376, 1984.

    Article  Google Scholar 

  12. Kendall-Taylor P, Atkinson S, Holcombe M, A specific IgG in Graves’ ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity, Brit Med J 288:1183–1186, 1984.

    Article  CAS  Google Scholar 

  13. Salvi M, How JS, Wall JR, Detection of autoantibodies against affinity purified orbital membrane antigens in Graves’ ophthalmopathy using a competitive binding ELISA, 61st Meeting, Am Thy Assoc, Abst T-8, 1986.

    Google Scholar 

  14. Baker JR, Weetman AP, Wartofsky L, Nutman T, Burman KD, Serum immunoglobulins in patients with Graves’ ophthalmopathy directed against unique determinants of porcine eye muscle, Clin Res 34:420A, 1986.

    Google Scholar 

  15. Wang, PW, Hiromatsu Y, Laryea E, Sosu L, How J, Wall JR, Immunologically mediated cytotoxicity against human eye muscle cells in Graves’ ophthalmopathy, J Clin Endocrinol Metab 63:316–322, 1986.

    Article  PubMed  CAS  Google Scholar 

  16. Sikorska H, Wall JR, Failure to detect eye muscle membrane specific antibodies in Graves’ ophthalmopathy, Brit Med J 291:604, 1985.

    Article  CAS  Google Scholar 

  17. Kriss JP, Radioisotopic thyroidolymphography in patients with Graves’ disease, J Clin Endocrinol Metab 31:315–324, 1970.

    Article  PubMed  CAS  Google Scholar 

  18. Konishi J, Herman MM, Kriss JP, Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane, Endocrinology 96:434–446, 1974.

    Article  Google Scholar 

  19. Kriss JP, Konishi J, Herman MM, Studies on the pathogenesis of Graves’ ophthalmopathy (with some related observations regarding therapy), Recent Prog Hormone Res 31:533–566, 1975.

    CAS  Google Scholar 

  20. Kriss JP, Mehdi SQ, Cell mediated lysis of lipid vesicles containing eye muscle proteins: implications regarding pathogenesis of Graves’ ophthalmopathy, Proc Natl Acad Sci USA 76:2003–2007, 1979.

    Article  PubMed  CAS  Google Scholar 

  21. Takeda Y, Kriss JP, Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum, J Clin Endocrinol Metab 44:46–55, 1977.

    Article  PubMed  CAS  Google Scholar 

  22. Ohtaki S, Endo Y, Horinouchi K, Yoshitake S, Ishikawa E, Circulating thyroglobulin-antithyroglobulin immune complex in thyroid diseases using enzyme-linked immunoassays, J Clin Endocrinol Metab 52:239–246, 1981.

    Article  PubMed  CAS  Google Scholar 

  23. Izumi M, Larsen PR, Correlation of sequential changes in serum, thyroglobulin, triiodothyronine, and 1-thyroxine in patients with Graves’ disease and subacute thyroiditis, Metabolism 27:582–593, 1967.

    Google Scholar 

  24. Kriss JP, Pleshakov V, Rosenblum AL, Holderness M, Sharp G, Utiger R, J Clin Endocrinol Metab 27:582–593, 1967.

    Article  PubMed  CAS  Google Scholar 

  25. Naffziger HC, Jones OW Jr, Surgical treatment of progressive exophthalmos following thyroidectomy, J Am Med Assoc 99:638–642, 1932.

    Google Scholar 

  26. Kriss JP, Pathogenesis and treatment of Graves’ ophthalmopathy, Thyroid Today 7, 1984.

    Google Scholar 

  27. Mullin BR, Levinson RE, Friedman A, Henson DE, Winand RJ, Kohn LD, Delayed hypersensitivity in Graves’ disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle, Endocrinology 100:351–366, 1979.

    Article  Google Scholar 

  28. Tao TW, Cheng P, Pham H, Leu SL, Kriss JP, Monoclonal antithyroglobulin antibodies derived from immunization of mice with human eye muscle and thyroid membranes, J Clin Endocrinol Metab 63:577–582, 1986.

    Article  PubMed  CAS  Google Scholar 

  29. Sattler H, Basedow’s Disease (translated by Marchand GW, Marchand JF), Grune and Stratton NY, pp 27-41, 1952.

    Google Scholar 

  30. Kuroki T, Ruf J, Whelan L, Miller A, Wall JR, Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders, Clin Exp Immunol 62:361–370, 1985.

    PubMed  CAS  Google Scholar 

  31. Winand R J, Kohn LD, The binding of H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue, Proc Natl Acad Sci 69:1711–1715, 1972.

    Article  PubMed  CAS  Google Scholar 

  32. Winand RJ, Kohn LD, Stimulation of adenylate cyclase activity in retro-orbital tissue membranes by thyroglobulin and exophthalmogenic factor derived from thyrotropin, J Biol Chem 250:6522–6526, 1975.

    PubMed  CAS  Google Scholar 

  33. Bolonkin D, Tate RL, Luber JH, Kohn LD, Experimental exophthalmos binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes, J Biol Chem 250:6516–6521, 1975.

    PubMed  CAS  Google Scholar 

  34. Kohn LD, Winand R J, Pathogenesis of human and experimental exophthalmos, In Proceedings of the Fourth International Congress of Endocrinology (ed. Scow RO), Excerpta Medica, Amsterdam, p 1150, 1982.

    Google Scholar 

  35. Rotella C, Zonefrati R, Toccafondi R, Valente WA, Kohn LD, Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves’ sera, J Clin Endocrinol Metab 62:357–367, 1986.

    Article  PubMed  CAS  Google Scholar 

  36. Bahn RS, Gorman CA, Woloschak GE, Johnson CM, Serum IgG from patients with Graves’ disease binds to a 23 KD protein from human retro-ocular connective tissue, 61st Meeting, Am Thy Assoc, Abst T9, 1986.

    Google Scholar 

  37. Kodama K, Sikorska H, Bayly R, Bandy-Dafoe P, Wall JR, Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy, J Clin Endocrinol Metab 59:67–73, 1984.

    Article  PubMed  CAS  Google Scholar 

  38. Donaldson SS, Bagshaw MA, Kriss JP, Supervoltage orbital radiotherapy for Graves’ ophthalmopathy, J Clin Endocrinol Metab 37:276, 1973.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Press, New York

About this chapter

Cite this chapter

Kriss, J.P., McDougall, I.R., Donaldson, S.S., Kraemer, H.C. (1987). Non-Thyroidal Complications of Graves’ Disease: Perspective On Pathogenesis And Treatment. In: Pinchera, A., Ingbar, S.H., McKenzie, J.M., Fenzi, G.F. (eds) Thyroid Autoimmunity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0945-1_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0945-1_31

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8258-7

  • Online ISBN: 978-1-4613-0945-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics